Open Access

[Retracted] Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non‑small cell lung cancer

  • Authors:
    • Liang Chang
    • Fangchao Gong
    • Hongfei Cai
    • Zhihong Li
    • Youbin Cui
  • View Affiliations

  • Published online on: November 14, 2022     https://doi.org/10.3892/ol.2022.13595
  • Article Number: 9
  • Copyright : © Chang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

January-2023
Volume 25 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chang L, Gong F, Cai H, Li Z and Cui Y: [Retracted] Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non‑small cell lung cancer. Oncol Lett 25: 9, 2023
APA
Chang, L., Gong, F., Cai, H., Li, Z., & Cui, Y. (2023). [Retracted] Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non‑small cell lung cancer. Oncology Letters, 25, 9. https://doi.org/10.3892/ol.2022.13595
MLA
Chang, L., Gong, F., Cai, H., Li, Z., Cui, Y."[Retracted] Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non‑small cell lung cancer". Oncology Letters 25.1 (2023): 9.
Chicago
Chang, L., Gong, F., Cai, H., Li, Z., Cui, Y."[Retracted] Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non‑small cell lung cancer". Oncology Letters 25, no. 1 (2023): 9. https://doi.org/10.3892/ol.2022.13595